Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A RAPID MICRO BIOSYSTEMS, Filed by: Longitude Capital Partners II, LLC

May 15, 2026 4:47 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by LVPII (as defined in the Explanatory Note below). LCPII (as defined in the Explanatory Note below) is the general partner of LVPII and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,267,511 shares of Class A Common Stock, outstanding as of March 31, 2026, as reported by the Issuer in the definitive proxy statement on Schedule 14A, filed with the United States Securities and Exchange Commission (the Commission) on April 8, 2026 (the Proxy Statement).


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by LVPII. LCPII is the general partner of LVPII and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,267,511 shares of Class A Common Stock, outstanding as of March 31, 2026, as reported by the Issuer in the Proxy Statement.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by LVPII. LCPII is the general partner of LVPII and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,267,511 shares of Class A Common Stock, outstanding as of March 31, 2026, as reported by the Issuer in the Proxy Statement.


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by LVPII. LCPII is the general partner of LVPII and may be deemed to have voting and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may each be deemed to share voting and dispositive power with respect to these securities. Based on 41,267,511 shares of Class A Common Stock, outstanding as of March 31, 2026, as reported by the Issuer in the Proxy Statement.


SCHEDULE 13G



Longitude Capital Partners II, LLC
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Longitude Venture Partners II, L.P.
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Longitude Prime Partners, LLC
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Longitude Prime Fund, L.P.
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, Authorized Signatory
Date:05/15/2026
Patrick G. Enright
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Date:05/15/2026
Juliet Tammenoms Bakker
Signature:/s/ Cristiana Blauth Oliveira
Name/Title:Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker
Date:05/15/2026

Categories

SEC Filings